Overview

This trial is active, not recruiting.

Condition leukemia, myeloblastic, acute
Treatment database
Sponsor King Faisal Specialist Hospital & Research Center
Start date October 2007
End date October 2020
Trial size 2000 participants
Trial identifier NCT00538278, RAC #2051-057

Summary

Prospective Database for Acute Myeloblastic Leukemia

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Endpoint classification safety study
Intervention model single group assignment
Masking open label
Primary purpose health services research

Primary Outcomes

Measure
safety and efficacy
time frame: 10 years

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Patients with AML

Additional Information

Principal investigator Naeem Chaudhri, MD
Trial information was received from ClinicalTrials.gov and was last updated in December 2011.
Information provided to ClinicalTrials.gov by King Faisal Specialist Hospital & Research Center.